Linkedin-in

Investor Relations

Lipocine is a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery. 

NASDAQLPCN
YearTrailing 12-MonthsCalendar Year 2026Calendar Year 2025Calendar Year 2024Calendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014Calendar Year 2013Calendar Year 2012Calendar Year 2011
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Proxy & Information StatementsOther
FormDescriptionDateFormat
10-K/AAmendment to a previously filed 10-KApr 30, 2012Open Amendment to a previously filed 10-K in HTML.Open Amendment to a previously filed 10-K in DOC file.Open Amendment to a previously filed 10-K in PDF file.Open Amendment to a previously filed 10-K in XLS file.
10-KAnnual report which provides a comprehensive overview of the company for the past yearMar 5, 2012Open Annual report which provides a comprehensive overview of the company for the past year in HTML.Open Annual report which provides a comprehensive overview of the company for the past year in DOC file.Open Annual report which provides a comprehensive overview of the company for the past year in PDF file.Open Annual report which provides a comprehensive overview of the company for the past year in XLS file.

Innovating beyond boundaries for patients

Krista Fogarty phone: (801) 994-7383 email: kf@lipocine.com